Author
Listed:
- Xingwu Wang
(Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China)
- Meng Zha
(Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China)
- Xiaocheng Zhao
(Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China)
- Peng Jiang
(University of Pennsylvania School of Medicine)
- Wenjing Du
(University of Pennsylvania School of Medicine)
- Andrew Y. H. Tam
(University of British Columbia)
- Yide Mei
(Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China)
- Mian Wu
(Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China)
Abstract
The tumour suppressor alternative reading frame (ARF) is one of the most frequently mutated proteins in human cancer. It has been well established that ARF is able to stabilize and activate p53 by directly inhibiting Mdm2. ARF-mediated p53 activation in response to oncogenic stress is thought to be an important determinant of protection against cancer. However, little is known regarding the control of ARF in cells. Here, we show that Siva1 is a specific E3 ubiquitin ligase of ARF. Siva1 physically interacts with ARF both in vitro and in vivo. Through direct interaction, Siva1 promotes the ubiquitination and degradation of ARF, which in turn affects the stability of p53. Functionally, Siva1 regulates cell cycle progression and cell proliferation in an ARF/p53-dependent manner. Our results uncover a novel regulatory mechanism for the control of ARF stability, thereby revealing an important function of Siva1 in the regulation of the ARF-Mdm2-p53 pathway.
Suggested Citation
Xingwu Wang & Meng Zha & Xiaocheng Zhao & Peng Jiang & Wenjing Du & Andrew Y. H. Tam & Yide Mei & Mian Wu, 2013.
"Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase,"
Nature Communications, Nature, vol. 4(1), pages 1-9, June.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2533
DOI: 10.1038/ncomms2533
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2533. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.